| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 29, 2021 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,200 | $3.98 | 2,200 |
| Nov 29, 2021 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,675 | $3.99 | 4,875 |
| Nov 29, 2021 |
Director, President and CEO
Trans History: 27
|
Director, President and CEO | Form 4 | Open market or private purchase of non-derivative or derivative security | 150 | $3.98 | 5,025 |
| Nov 19, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 22,500 | $0.56 | 55,500 |
| Nov 19, 2021 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 22,500 | -- | 177,500 |
| Aug 17, 2021 |
Director
Trans History: 17
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 10
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 10
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 13
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.